|
시장보고서
상품코드
1338906
비타민 D 요법 시장 점유율, 규모, 동향, 산업 분석 보고서 : 투여 경로별, 연령대별, 구매 패턴별, 용도별, 지역별, 부문별 예측(2023-2032년)Vitamin D Therapy Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral); By Age Group; By Purchase Pattern; By Application; By Region; Segment Forecast, 2023 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 비타민 D 요법 세계 시장 규모는 2032년까지 80억 7,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
세계보건기구(WHO)에 따르면, 전 세계적으로 약 10억 명이 비타민 D 결핍 또는 결핍증을 앓고 있는 것으로 추정됩니다. 이는 비타민 D 요법제 시장이 크게 성장하고 있음을 보여줍니다. 인도 전역에서 실시된 여러 조사 결과, 모든 연령대에서 비타민 D 결핍이 광범위하게 발생하고 있는 것으로 나타났습니다. 신생아 및 수유부(0-6개월)의 비타민 D 결핍 유병률은 62.7%, 6-60개월의 경우 46.8%, 5-20세의 경우 37.8-97.5%로 추정됩니다. 종합적인 검토에 따르면 5세에서 20세 사이의 어린이 중 37.8%에서 97.5%가 비타민 D 결핍증입니다. 이는 시장 성장을 위한 광범위한 기회를 창출할 것으로 보입니다.
전 세계 많은 사람들이 비타민 D를 충분히 섭취할 수 없는 생활방식과 식습관을 가지고 있습니다. 예를 들어, 햇빛에 노출되지 않는 도시 거주자나 제한적인 식습관을 가진 사람들은 비타민 D 결핍의 위험에 노출될 수 있습니다. 이에 따라 비타민 D 결핍을 해결하기 위한 비타민 D 보충제 및 치료제에 대한 수요가 증가하고 있습니다. 세계은행에 따르면 현재 전 세계 인구의 50% 이상이 도시에 거주하고 있습니다. 2045년까지 도시 거주 인구는 2배 이상 증가한 60억 명에 달할 것으로 예상됩니다. 이는 시장 성장과 수요를 더욱 촉진할 것으로 보입니다.
비타민 D 요법 시장 보고서 하이라이트
경구용 부문은 편의성, 효과, 다양성, 가용성, 비용 효율성 등의 장점으로 인해 더 높은 성장세를 보일 것으로 예상됩니다.
고령자 부문은 결핍증 위험 증가, 고령화 인구 증가, 만성질환 유병률 증가로 인해 높은 성장률을 보이고 있습니다.
처방약 부문은 처방약에 대한 환자 선호도, 특허 보호, 의료진의 처방 관행으로 인해 더 높은 성장세를 보일 것으로 예상됩니다.
골다공증 분야는 전 세계 골다공증 유병률의 증가와 뼈 건강 유지에 있어 비타민 D의 중요성에 대한 인식이 높아지면서 괄목할 만한 성장률을 보일 것으로 예상됩니다.
아시아태평양은 높은 비타민 D 결핍증 발병률, 정부의 노력, 생활습관 등으로 인해 상당한 성장률을 보일 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 비타민 D 요법 시장에 관한 인사이트
- 비타민 D 요법 - 업계 현황
- 비타민 D 요법 시장 역학
- 성장 촉진요인과 기회
- 경구약 수요 증가
- 소매 약국 수요 증가
- 성장 억제요인과 과제
- 숙련된 전문가 부족
- 성장 촉진요인과 기회
- PESTLE 분석
- 비타민 D 요법 업계 동향
- 밸류체인 분석
- COVID-19 감염증의 영향 분석
제5장 세계의 비타민 D 요법 시장, 투여 경로별
- 주요 조사 결과
- 서론
- 어랄
- 비경구
제6장 세계의 비타민 D 요법 시장, 용도별
- 주요 조사 결과
- 서론
- 골다공증
- 구루병
- 피부질환
- 근력저하
- 자가면역질환
제7장 세계의 비타민 D 요법 시장, 연령층별
- 주요 조사 결과
- 서론
- 아동
- 성인
- 시니어 성인
제8장 세계의 비타민 D 요법 시장, 구입 패턴별
- 주요 조사 결과
- 서론
- 일반용 의약품
- 처방약
제9장 세계의 비타민 D 요법 시장, 지역별
- 주요 조사 결과
- 서론
- 비타민 D 요법 시장 평가, 지역별, 2019-2032년
- 비타민 D 요법 시장 - 북미
- 북미 : 비타민 D 요법 시장, 투여 경로별, 2019-2032년
- 북미 : 비타민 D 요법 시장, 구입 패턴별, 2019-2032년
- 북미 : 비타민 D 요법 시장, 용도별, 2019-2032년
- 북미 : 비타민 D 요법 시장, 연령층별, 2019-2032년
- 비타민 D 요법 시장 - 미국
- 비타민 D 요법 시장 - 캐나다
- 비타민 D 요법 시장 - 유럽
- 유럽 : 비타민 D 요법 시장, 투여 경로별, 2019-2032년
- 유럽 : 비타민 D 요법 시장, 구입 패턴별, 2019-2032년
- 유럽 : 비타민 D 요법 시장, 용도별, 2019-2032년
- 유럽 : 비타민 D 요법 시장, 연령층별, 2019-2032년
- 비타민 D 요법 시장 - 영국
- 비타민 D 요법 시장 - 프랑스
- 비타민 D 요법 시장 - 독일
- 비타민 D 요법 시장 - 이탈리아
- 비타민 D 요법 시장 - 스페인
- 비타민 D 요법 시장 - 네델란드
- 비타민 D 요법 시장 - 러시아
- 비타민 D 요법 시장 - 아시아태평양
- 아시아태평양 : 비타민 D 요법 시장, 투여 경로별, 2019-2032년
- 아시아태평양 : 비타민 D 요법 시장, 구입 패턴별, 2019-2032년
- 아시아태평양 : 비타민 D 요법 시장, 용도별, 2019-2032년
- 아시아태평양 : 비타민 D 요법 시장, 연령층별, 2019-2032년
- 비타민 D 요법 시장 - 중국
- 비타민 D 요법 시장 - 인도
- 비타민 D 요법 시장 - 일본
- 비타민 D 요법 시장 - 말레이시아
- 비타민 D 요법 시장 - 인도네시아
- 비타민 D 요법 시장 - 한국
- 비타민 D 요법 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 비타민 D 요법 시장, 투여 경로별, 2019-2032년
- 중동 및 아프리카 : 비타민 D 요법 시장, 구입 패턴별, 2019-2032년
- 중동 및 아프리카 : 비타민 D 요법 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : 비타민 D 요법 시장, 연령층별, 2019-2032년
- 비타민 D 요법 시장 - 사우디아라비아
- 비타민 D 요법 시장 - 남아프리카공화국
- 비타민 D 요법 시장 - 이스라엘
- 비타민 D 요법 시장 - 아랍에미리트
- 비타민 D 요법 시장 - 라틴아메리카
- 라틴아메리카 : 비타민 D 요법 시장, 투여 경로별, 2019-2032년
- 라틴아메리카 : 비타민 D 요법 시장, 구입 패턴별, 2019-2032년
- 라틴아메리카 : 비타민 D 요법 시장, 용도별, 2019-2032년
- 라틴아메리카 : 비타민 D 요법 시장, 연령층별, 2019-2032년
- 비타민 D 요법 시장 - 멕시코
- 비타민 D 요법 시장 - 브라질
- 비타민 D 요법 시장 - 아르헨티나
제10장 경쟁 상황
- 확장과 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- GlaxoSmithKline
- Pfizer
- Abbott
- Sanofi
- Merck
- Torrent Pharmaceuticals
- Novartis International
- Alkem Laboratories
- Sun Pharmaceutical
- Cadila Healthcare
The global vitamin D therapy market size is expected to reach USD 8.07 billion by 2032, according to a new study by Polaris Market Research. The report "Vitamin D Therapy Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral); By Age Group; By Purchase Pattern; By Application; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
According to the World Health Organization (WHO), an estimated 1 Bn people across the globe have vitamin D insufficiency or deficiency. This indicates a large and growing market for vitamin D therapies. Several studies conducted across India in various regions have revealed a widespread incidence of vitamin D insufficiency in people of all ages. According to estimates, the prevalence of Vit-D deficiency ranges from 62.7% in newborns and breast-feeding populations (0-6 months) to 46.8% in children aged 6 to 60 months and from 37.8 to 97.5% in kids aged 5 to 20. According to a comprehensive review, between 37.8 and 97.5% of children aged 5 to 20 have vitamin D deficiency. This will create a wide range of opportunities for the growth of the market.
Many people around the world are adopting lifestyles and dietary habits that do not provide sufficient vitamin D. For example, people who live in urban areas with little exposure to sunlight or those who follow restrictive diets may be at risk of vitamin D insufficiency. This has led to increased demand for vitamin D supplements and therapies to address these deficiencies. According to the World Bank, Currently, more than 50% of the world's population resides in cities. The number of people living in urban areas will more than double to 6 billion by 2045. This will further fuel the growth and demand for the market.
Vitamin D Therapy Market Report Highlights
Oral segment is anticipated to witness higher growth due to its advantages such as convenience, effectiveness, versatility, availability, and cost-effectiveness
Senior Adults segment accounted for the higher growth rate owing to the increased risk of deficiency, the growing aging population, and the higher incidence of chronic diseases.
Prescription Drugs segment is expected to have a higher growth due to patient preference for prescription drugs, patent protection, and healthcare provider prescribing habits.
Osteoporosis segment is projected to experience a significant growth rate due to the increasing prevalence of osteoporosis worldwide and growing awareness of the importance of vitamin D in maintaining bone health.
Asia Pacific is expected to grow at a significant growth rate owing to the high incidence of vitamin D deficiency, government initiatives and lifestyle.
The global players include: GSK, Pfizer, Abbott, Sanofi, Merck, Torrent Pharmaceuticals, Novartis International, Alkem Laboratories, Sun Pharmaceutical Industries and Cadila Healthcare.
Polaris Market Research has segmented the Vitamin D Therapy market report based on route of administration, age group, purchase pattern, application and region:
Vitamin D Therapy, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Oral Route
- Parenteral Route
Vitamin D Therapy, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)
- Children
- Adults
- Senior Adults
Vitamin D Therapy, Purchase Pattern Outlook (Revenue - USD Billion, 2019 - 2032)
- OTC Drugs
- Prescription Drugs
Vitamin D Therapy, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Osteoporosis
- Rickets
- Skin Diseases
- Muscle Weakness
- Autoimmune Disorders
Vitamin D Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Vitamin D Therapy Market Insights
- 4.1. Vitamin D Therapy - Industry Snapshot
- 4.2. Vitamin D Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Demand of Oral Drugs
- 4.2.1.2. Increasing Demand for Retail Pharmacies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of skilled professionals
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Vitamin D Therapy Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Vitamin D Therapy Market, by Route of Administration
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 5.3. Oral
- 5.3.1. Global Vitamin D Therapy Market, by Oral, by Region, 2019-2032 (USD Billion)
- 5.4. Parenteral
- 5.4.1. Global Vitamin D Therapy Market, by Parenteral, by Region, 2019-2032 (USD Billion)
6. Global Vitamin D Therapy Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 6.3. Osteoporosis
- 6.3.1. Global Vitamin D Therapy Market, by Osteoporosis, by Region, 2019-2032 (USD Billion)
- 6.4. Rickets
- 6.4.1. Global Vitamin D Therapy Market, by Rickets, by Region, 2019-2032 (USD Billion)
- 6.5. Skin Diseases
- 6.5.1. Global Vitamin D Therapy Market, by Skin Diseases, by Region, 2019-2032 (USD Billion)
- 6.6. Muscle Weakness
- 6.6.1. Global Vitamin D Therapy Market, by Muscle Weakness, by Region, 2019-2032 (USD Billion)
- 6.7. Autoimmune Disorders
- 6.7.1. Global Vitamin D Therapy Market, by Autoimmune Disorders, by Region, 2019-2032 (USD Billion)
7. Global Vitamin D Therapy Market, by Age Group
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 7.3. Children
- 7.3.1. Global Vitamin D Therapy Market, by Children, by Region, 2019-2032 (USD Billion)
- 7.4. Adults
- 7.4.1. Global Vitamin D Therapy Market, by Adults, by Region, 2019-2032 (USD Billion)
- 7.5. Senior Adults
- 7.5.1. Global Vitamin D Therapy Market, by Senior Adults, by Region, 2019-2032 (USD Billion)
8. Global Vitamin D Therapy Market, by Purchase Pattern
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 8.3. OTC Drugs
- 8.3.1. Global Vitamin D Therapy Market, by OTC Drugs, by Region, 2019-2032 (USD Billion)
- 8.4. Prescription Drugs
- 8.4.1. Global Vitamin D Therapy Market, by Prescription Drugs, by Region, 2019-2032 (USD Billion)
9. Global Vitamin D Therapy Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Vitamin D Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Vitamin D Therapy Market - North America
- 9.3.1. North America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.2. North America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.3.3. North America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.3.4. North America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.5. Vitamin D Therapy Market - U.S.
- 9.3.5.1. U.S.: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.6. Vitamin D Therapy Market - Canada
- 9.3.6.1. Canada: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4. Vitamin D Therapy Market - Europe
- 9.4.1. Europe: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.2. Europe: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.3. Europe: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.4. Europe: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.5. Vitamin D Therapy Market - UK
- 9.4.5.1. UK: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.6. Vitamin D Therapy Market - France
- 9.4.6.1. France: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.6.2. France: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.6.3. France: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.6.4. France: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.7. Vitamin D Therapy Market - Germany
- 9.4.7.1. Germany: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.8. Vitamin D Therapy Market - Italy
- 9.4.8.1. Italy: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.9. Vitamin D Therapy Market - Spain
- 9.4.9.1. Spain: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.10. Vitamin D Therapy Market - Netherlands
- 9.4.10.1. Netherlands: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.11. Vitamin D Therapy Market - Russia
- 9.4.11.1. Russia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5. Vitamin D Therapy Market - Asia Pacific
- 9.5.1. Asia Pacific: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.5. Vitamin D Therapy Market - China
- 9.5.5.1. China: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.5.3. China: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.5.4. China: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.6. Vitamin D Therapy Market - India
- 9.5.6.1. India: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.6.3. India: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.6.4. India: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.7. Vitamin D Therapy Market - Japan
- 9.5.7.1. Japan: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.8. Vitamin D Therapy Market - Malaysia
- 9.5.8.1. Malaysia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.9. Vitamin D Therapy Market - Indonesia
- 9.5.9.1. Indonesia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.10. Vitamin D Therapy Market - South Korea
- 9.5.10.1. South Korea: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.6. Vitamin D Therapy Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.5. Vitamin D Therapy Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.6. Vitamin D Therapy Market - South Africa
- 9.6.6.1. South Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.7. Vitamin D Therapy Market - Israel
- 9.6.7.1. Israel: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.8. Vitamin D Therapy Market - UAE
- 9.6.8.1. UAE: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.7. Vitamin D Therapy Market - Latin America
- 9.7.1. Latin America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.5. Vitamin D Therapy Market - Mexico
- 9.7.5.1. Mexico: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.6. Vitamin D Therapy Market - Brazil
- 9.7.6.1. Brazil: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.7. Vitamin D Therapy Market - Argentina
- 9.7.7.1. Argentina: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. GlaxoSmithKline
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Pfizer
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Abbott
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Sanofi
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Merck
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Torrent Pharmaceuticals
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Novartis International
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Alkem Laboratories
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Sun Pharmaceutical
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Cadila Healthcare
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
비교리스트